AstraZeneca’s Farxiga receives US FDA Priority Review to treat patients with chronic kidney disease
AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D).…
Tamil Nadu: Doctors warned, Chronic Kidney Disease Becoming Rampant
Doctors in Madurai shared their concerned and said Around 65,000 chronic kidney disease (CKD) patients are reported in Tamil Nadu and around 15,000 patients out of them need advanced care…
As Chronic Kidney Diseases (CKD) rise, Kidney Care at Home is becoming norm
New Delhi: Given the huge burden of kidney diseases and hospitals lacking beds to accommodate them, kidney care at home is becoming the norm. Sir Ganga Ram Hospital launched Kidney…
